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Although advances in intensive care have enabled more patients to
survive an acute critical illness, they also have created a large and
growing population of chronically critically ill patients with pro-
longed dependence on mechanical ventilation and other intensive
care therapies. Chronic critical illness is a devastating condition:
mortality exceeds that for most malignancies, and functional de-
pendence persists for most survivors. Costs of treating the chroni-
cally critically ill in the United States already exceed $20 billion and
are increasing. In this article, we describe the constellation of clinical
features that characterize chronic critical illness. We discuss the
outcomes of this condition including ventilator liberation, mortality,
and physical and cognitive function, noting that comparisons
among cohorts are complicated by variation in defining criteria
and care settings. We also address burdens for families of the
chronically critically ill and the difficulties they face in decision-
making about continuation of intensive therapies. Epidemiology
and resource utilization issues are reviewed to highlight the impact
of chronic critical illness on our health care system. Finally, we
summarize the best available evidence for managing chronic critical
illness, including ventilator weaning, nutritional support, rehabili-
tation, and palliative care, and emphasize the importance of efforts
to prevent the transition from acute to chronic critical illness. As
steps forward for the field, we suggest a specific definition of chronic
critical illness, advocate for the creation of a research network
encompassing a broad range of venues for care, and highlight areas
for future study of the comparative effectiveness of different
treatment venues and approaches.
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Although advances in intensive care have enabled more pa-
tients to survive an acute critical illness, they have also created
a large and growing population of patients with prolonged
dependence on mechanical ventilation and other intensive care
therapies. The term ‘‘chronically critically ill’’ was coined for
this group by Girard and Raffin in a 1985 article that asked in its
title, ‘‘to save or let die’’? (1). They focused on patients who
survived an initial episode of critical illness but remained
dependent on intensive care, neither dying in the acute period
of intensive care unit (ICU) treatment nor recovering. Esti-
mates indicate that there are more than 100,000 such patients in
the United States at any point in time, and increasing numbers
in some other countries. Chronic critical illness is a devastating
condition for patients and their families and, at a cost exceeding
$20 billion each year, for the U.S. health care system as a whole.
Incidence and expenditures are rising as more older adults, who
already comprise the majority of chronically critically ill pa-
tients, receive aggressive medical and surgical treatments.
In this article, we review clinical features and outcomes of
the chronic critical illness syndrome, its impact on the health
care system, and the challenges it presents for treatment and
decision-making. Data are drawn from a search of the Medline
database from 1975 to March 2010 for all English language
articles using the terms ‘‘chronic critical illness’’ or ‘‘chronically
critically ill,’’ ‘‘prolonged critical illness,’’ ‘‘prolonged mechan-
ical ventilation,’’ ‘‘prolonged ventilator weaning,’’ ‘‘post-ICU,’’
‘‘long-term acute care facility,’’ ‘‘respiratory care unit,’’ and
‘‘tracheostomy’’ or ‘‘tracheotomy’’; we also hand-searched
reference lists and author files.
CLINICAL FEATURES OF THE CHRONIC CRITICAL
ILLNESS SYNDROME
The hallmark of chronic critical illness is respiratory failure
requiring prolonged dependence on mechanical ventilation.
Although the term ‘‘prolonged mechanical ventilation’’ has been
used in the literature to describe periods of ventilator depen-
dence ranging from 2 days to 4 weeks (2–5), this period is usually
measured in weeks for the chronically critically ill. Besides
prolonged ventilator dependence, evidence suggests that chronic
critical illness is a syndrome comprising additional characteristic
features. These include profound weakness attributed to myop-
athy, neuropathy, and alterations of body composition including
loss of lean body mass, increased adiposity, and anasarca (6);
distinctive neuroendocrine changes including loss of pulsatile
secretion of anterior pituitary hormones, contributing to low
target organ hormone levels and impaired anabolism (7, 8);
increased vulnerability to infection, often with multiresistant
microbial organisms (9, 10); brain dysfunction manifesting as
coma or delirium that is protracted or permanent (11); and skin
breakdown associated with nutritional deficiencies, edema, in-
continence, and prolonged immobility (12). Patient reports
document significant distress from symptoms including pain,
thirst, dyspnea, depression, and anxiety, and from inability to
communicate during endotracheal intubation (13). This constel-
lation of features, summarized in Figure 1, serves as a framework
for the clinical definition of chronic critical illness. Some of these
features (e.g., brain dysfunction, symptom distress) may be
present during acute critical illness (or other conditions), but
their prolonged duration and intensity in the chronic phase of
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critical illness are distinctive. Other features (e.g., changes in
body composition and neuroendocrine patterns) have been de-
scribed only in the chronic phase. Chronic critical illness is
uniquely characterized by the presence of these features as
a clinical constellation in association with prolonged dependence
on mechanical ventilation.
Between 5 and 10% of patients who require mechanical
ventilation for acute conditions develop chronic critical illness
(14–16). Patients from any type of medical or surgical ICU can be
affected. On the basis of data from statewide databases, the mean
(SD) age for adult patients is 65 (15) years (17, 18); for those in
specialized weaning facilities, it is in the eighth decade (17, 19).
Patients are evenly divided according to sex, and comorbidities
are common (11, 17–19). Patients with trauma as an admitting
diagnosis are usually younger, more likely male, and have fewer
comorbidities (18). More than one-third of chronically critically
ill patients receive care in teaching hospitals (18).
OUTCOMES
Generalization of outcomes from published reports is compli-
cated by variation in study populations described as chronically
critically ill, in definitions of outcomes of interest, and in post–
acute care practices that affect hospital use. A threshold period
of mechanical ventilation, ranging from 2 to 30 days, has been
used to define the majority of cohorts for longitudinal studies
(2–5). To limit the heterogeneity of these cohorts and thereby
improve comparability of outcomes across different studies,
a consensus conference established a formal definition for
prolonged mechanical ventilation: at least 21 consecutive days
on the ventilator for more than 6 hours/day (2). Other cohort
studies have identified chronically critically ill patients by
elective placement of a tracheotomy to facilitate prolonged
ventilation and weaning efforts (20–23). Referral for tracheot-
omy reflects the clinician’s judgment that the patient will
neither wean nor die in the immediate future and thus provides
a point of demarcation between acute and chronic critical illness
that is both clinically meaningful and practical. In population-
based studies, International Classification of Diseases (ICD)
coding and Diagnosis-Related Groups (DRGs) have been used,
respectively, to identify patients requiring specified threshold
periods of mechanical ventilation and those receiving tracheot-
omy for failure to wean from the ventilator (17, 18). One study
validated an algorithm defining ‘‘prolonged mechanical venti-
lation’’ on the basis of coding as either (1) ICD-9-96.72
(mechanical ventilation . 96 h) plus an ICU length of stay of
at least 21 days or (2) classification in DRG 541/542 (tracheot-
omy for a condition other than head, neck, or face disease)
(sensitivity, 97.6%; specificity, 96.4%) (17). To address the
impact of cohort definition on outcome results, another study
compared outcomes of cohorts from the same hospital that were
defined either by placement of tracheotomy after at least 96
hours of mechanical ventilation or by ventilation for at least 21
days (24). In that study, patients identified by tracheotomy had
higher rates of 1-year survival than those ventilated for at least
21 days (52 vs. 42%), although both definitions captured a group
of patients with high resource use and poor clinical outcomes.
Ventilator Liberation
Between 30 and 53% of chronically critically ill patients are
liberated from mechanical ventilation (defined as discharged
alive and breathing without assistance) in the acute care hospital
(14, 25). Average time to ventilator liberation varies with severity
and type of illness or injury, but typically ranges from 16 to 37
days after intubation for respiratory failure (14, 17, 24, 25). Most
patients who fail to achieve ventilator independence within 60
days do not do so later (26, 27). Better outcomes are reported for
some specialized weaning units, but they often select patients
with higher potential for ventilator liberation and rehabilitation
(10, 26, 28). Reimbursement incentives discourage some weaning
facilities from admitting patients who have severe irreversible
pulmonary processes, require hemodialysis, or have profound
neurologic injuries; outcomes in such facilities may be more
favorable because of this admission bias.
Mortality
Although patients who remain ventilator dependent are at
higher risk of death, successful weaning does not ensure long-
term survival as most patients with chronic critical illness have
underlying comorbid conditions, residual organ dysfunction,
and intercurrent complications (Table 1). Acute care hospital
mortality for unselected patients is generally reported in the
range of 20–49% (11, 17, 24, 25). One-year mortality across
study populations is 48–68% with little change over the past 20
Figure 1. The syndrome of chronic critical illness. Most
chronically critically ill patients are older adults who have
underlying comorbid conditions and develop sepsis and
other acute comorbidities with treatment for acute med-
ical, surgical, neurologic, or cardiac critical illness. Beyond
prolonged ventilator dependence, which is its hallmark,
increasing evidence indicates that chronic critical illness is
a syndrome encompassing other characteristic clinical
features and affecting multiple systems and organs.
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years (5, 10, 14, 24, 25, 28). Compared with patients requiring
short-term ventilation, the risk of death in chronically critically
ill patients remains particularly high between 60 and 100 days
after initiation of mechanical ventilation (24).
Functional and Cognitive Impairments
Nearly all patients with chronic critical illness leave the hospital
with profound impairments of physical function, cognitive
status, or both, and most therefore require institutional care
(11, 14, 29–31). Hospital readmission rates during the year after
hospital discharge exceed 40% (32). Patients discharged to
extended care facilities who cannot be sufficiently rehabilitated
for return to home by 6 months usually remain institutionalized
until death (33). Across multiple studies, fewer than 12% of
chronically critically ill patients were alive and independent 1
year after their acute illness (11, 28, 31). Long-term survivors
who are able to respond to surveys of health-related quality of
life (HRQOL) typically report better emotional and social
function than physical function or symptom experience (14,
34). Although these findings are consistent with studies of
HRQOL in survivors of acute critical illness, which indicate
that some patients can adapt emotionally to profound changes
in health status (35), interpretation must be tempered by the
fact that the majority of chronically critically ill patients do not
survive 1 year and most survivors lack sufficient cognitive
function to respond to HRQOL surveys (11).
Family Burdens
Chronic critical illness also imposes heavy burdens on families,
who experience high rates of depression and practical and
financial hardships (36, 37). Evidence from studies of informal
caregivers of patients requiring prolonged mechanical ventila-
tion indicates that depressive symptoms are more severe in this
group than among caregivers of patients with Alzheimer’s
disease or spinal cord injury and that depression continues for
months after the patient’s discharge from the hospital (37).
These caregivers also report a decline in physical health and
increase in ‘‘caregiving overload’’ during the postdischarge
period (37). In a study of post-ICU caregiver burden, multivari-
able regression analysis identified the placement of a tracheot-
omy in the ICU as a significant predictor of lifestyle disruption
for informal caregivers of ICU survivors at 1 year after ICU
admission (38). Another study, focusing on patients who un-
derwent tracheotomy after at least 4 days of mechanical
ventilation or ventilation for at least 21 days, found that 61%
of 1-year survivors still required daily assistance from informal
caregivers, who reported ‘‘a lot’’ or ‘‘severe’’ stress from
caregiving; 84% of these caregivers had either quit work or
significantly changed work hours to accommodate the patient’s
caregiving needs (39). Several studies have shown that burdens
for families are not limited to those who provide the care at
home (36, 37); depressive symptoms, caregiving overload, and
physical deterioration may actually be more severe among
families of patients who are institutionalized than of those
who return home (37). In addition, families of patients with
protracted critical illness often face significant losses of income
and/or savings, even if the patient is insured (40).
Mortality Prediction
Evidence suggests that several patient-related factors contribute
significantly to variation in clinical outcomes. Advanced age and
residual organ failures, both common characteristics of chron-
ically critically ill patients, are associated with higher mortality,
as is poor prior functional status (29, 31, 41). Younger patients
with trauma initiating critical illness have had more favorable
outcomes (21). Neither the APACHE (Acute Physiology and
Chronic Health Evaluation) system nor other models for
predicting mortality of acutely critically ill patients are valid
for chronic critical illness (41, 42). A simple mortality prediction
model was developed to identify chronically critically ill pa-
tients at high risk for 3-month and 1-year mortality (25);
a multicenter study to provide external validation of this model
is ongoing. The mortality model does not address prognosis for
functional or cognitive recovery, which many patients and
families consider as seriously as prospects for survival (20).
Deficiencies in Physician–Patient–Family Communication
Studies reveal that these clinical outcomes are poorly under-
stood by family decision-makers for chronically critically ill
patients and even by physicians. In questionnaire-based in-
terviews conducted shortly after tracheotomy, ICU patients and
surrogates reported that key aspects informing the decision to
provide prolonged life support were routinely omitted by
physicians; for example, 80 and 93% of the respondents re-
ceived no information about possible functional dependency at
hospital discharge or about expected 1-year survival, respec-
tively (20). Similarly, qualitative interviews of family surrogates
in another study found that three-quarters lacked accurate
estimates of survival, functional status, and caregiving needs
for patients requiring prolonged mechanical ventilation; 93%
expected that the patient would survive for at least 1 year, and
less than 30% anticipated any functional limitation or other
TABLE 1. OUTCOMES OF CHRONIC CRITICAL ILLNESS RELATIVE TO COHORT DEFINITION*
Cohort Definition Ventilation for >14 d Ventilation for >21 d
Tracheotomy for Prolonged
Mechanical Ventilation
Study (reference) Combes et al. (34) Carson et al. (25) Cox et al.† (24) Cox et al.† (24) Engoren et al. (14)
n 347 200 114 267 347
Age (yr), median (IQR) or mean 6 SD 63 6 14, 67 6 13‡ 58 (42–69) 66 (47–74) 66 (45–75) 64, 71x
Duration of ventilation, median (IQR)
or mean 6 SD
36 6 25, 37 6 28‡ 35 (26–51) 27 (23–36) 16 (10–24) 23–30k
Hospital length of stay, median (IQR) — 51 (36–72) 39 (30–52) 29 (22–38) 28–37k
Died in hospital, % 43 41 31 20 22
Discharged home, % — 11 4 7 —
Alive at 12 mo, % 32 48 42 52 50
* Studies were selected if they were prospective cohort studies published after 2000, enrolled patients in the acute hospital setting who received at least 14 days of
mechanical ventilation, and reported 12-month survival for comparison.
† Study reporting outcomes of two different cohorts distinguished by definition.
‡ Mean 6 SD for ICU survivors and for nonsurvivors, respectively.
x Median for hospital survivors and for nonsurvivors, respectively.
k Range of medians for hospital survivors who were ventilator dependent, liberated from ventilator but with tracheotomy, or liberated and decannulated; and for
nonsurvivors.
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impairment of quality of life (39). These expectations diverged
dramatically from those held by the patients’ physicians, who
were less optimistic about chances for 1-year survival (expected
by 44% of physicians) and much less so for functional recovery
(expected by 6% of physicians). Both families and physicians
significantly overestimated the patients’ actual outcomes (39).
IMPACT ON HEALTH CARE SYSTEM
Chronic critical illness is a serious and growing problem for the
U.S. health care system and an emerging challenge in other
countries (23, 43). In population-based studies in the United
States, the incidence of respiratory failure requiring mechanical
ventilation has been increasing by as much as 5.5% per year (44,
45) and will soon increase at an even faster rate as Baby
Boomers pass age 60, when the risk of respiratory failure rises
dramatically (46). Numbers of the chronically critically ill, who
are mostly older adults, will increase as much or more. Analysis
of a state database of hospital discharges showed that the
incidence of tracheotomy for prolonged ventilation nearly tri-
pled between 1993 and 2002, from 8.3 per 100,000 population to
24.2 per 100,000 (18). Another population-based study pro-
jected that the number of patients requiring mechanical venti-
lation for at least 7 days in the United States will more than
double from 250,000 in 2000 to more than 600,000 in 2020 (44).
Although the chronically critically ill account for fewer than 10%
of those receiving mechanical ventilation, they consume between
20 and 40% of ICU bed days and other critical care resources (16,
18). Because functional limitations are common, even patients
who recover sufficiently to permit discharge from an inpatient
facility typically require paid caregiving as outpatients or family
members must leave jobs to provide ongoing care. The overall
cost to the health care system for the management of chronic
critical illness already exceeds an estimated $20 billion per year
(29) and is expected to climb with increases in the incidence of
this syndrome and in overall expenditures for critical care, which
nearly doubled between 1985 and 2000 and represent 13% of all
hospital costs in the United States (47).
Cost-Effectiveness
A cost-effectiveness analysis calculated that providing pro-
longed mechanical ventilation to Medicare-eligible patients
with multiple comorbid conditions exceeds $200,000 for each
quality-adjusted life year gained, as compared with patients who
had life-sustaining therapies withdrawn before Day 14 of
mechanical ventilation (29). This analysis demonstrated that
incremental costs associated with prolonged life support were
most sensitive to acute hospital costs (rather than post–acute
care facility costs) and hospital readmissions. Innovations to
reduce costs in addition to improving clinical outcomes are
needed. A specialized disease management program failed to
reduce the risk of readmission for patients ventilated for 3 days
or more, but it was associated with a decreased length of stay
during rehospitalization from 16 to 11.4 days, yielding an
average cost saving of more than $50,000 per patient (3).
Venues of Care
Patients with chronic critical illness receive care across a range
of venues (Table 2). Besides acute care hospitals, these include
long-term acute care facilities, skilled nursing facilities,
inpatient rehabilitation facilities, and chronic ventilator facil-
ities, with various resources for the complex needs and de-
pendencies that characterize the chronically critically ill.
Diagnosis-Related Groups (DRGs) covering these patients
are among the most heavily weighted, supporting relatively
high reimbursement to acute care hospitals. Nevertheless, high
costs for long-stay outliers are a burden for these hospitals,
creating an incentive for transferring chronically critically ill
patients to post–acute care facilities for further attempts at
weaning and rehabilitation. Such facilities have become profit-
able to operate, contributing to rapid expansion of the for-
profit long-term acute care (LTAC) industry, which grew at
a rate of 12% per year between 1993 and 2003 (48). Medicare
payments to LTACs, which cover more than 80% of their
discharges, have increased by 15% annually (48). Costs over
the entire episode of illness are lower for chronically critically
ill Medicare beneficiaries who are transferred on mechanical
ventilation to LTACs (48), probably because of lower nurse-
to-patient ratios and staff salaries, and efficiencies in ventilator
weaning and rehabilitation services. Data are inconclusive,
however, on whether patient survival is affected by LTAC
transfer (48). Reports by individual LTACs suggest that
patients are being transferred from acute care hospitals earlier
in the course of critical illness, with higher degrees of illness
severity (49). If these trends of earlier transfer to LTACs
continue, the cost savings associated with care in such facilities
may be offset by an increase in rates of subsequent readmis-
sions to acute care hospitals. Congress has mandated reform of
payment to post–acute care facilities; this process is currently
in the demonstration phase and has expanded to address the
role of acute care hospitals in providing care for chronically
critically ill patients (50).
TREATMENT CHALLENGES
Even as attention focuses increasingly on chronic critical illness
from the perspectives of epidemiologic and health services,
empirical research to define effective methods of treatment
remains scant. Most data on specific therapeutic approaches
derive from descriptive studies conducted in single centers,
TABLE 2. MAIN VENUES FOR CARE OF THE CHRONICALLY CRITICALLY ILL*
Nursing Intensity/Cost Patient Acuity Specialized Rehabilitation Approach
Acute care hospitals
Intensive care units 1 1 1 1 1 1 1
Critical care stepdown units 1 1 1 1 1
Specialized weaning units 1 1 1 1 1 1 1
Medical–surgical ward 1 1 1
Long-term acute care (LTAC)
or long-term care hospitals (LTCH)
1 1 1 1 1 1 1
Skilled nursing facilities 1 1 1 1
* Depending on geographic location and available resources within and outside the acute hospital setting, most chronically critically ill patients in the United States are
cared for in acute care hospitals, long-term acute care facilities or, less commonly, skilled nursing facilities. Relative levels of nursing intensity/cost, patient acuity, and
availability of specialized rehabilitation are noted for the typical facility in these venue categories, although there is variation within as well as across categories.
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leaving clinicians to rely mainly on their own experience and
extrapolation of evidence from studies of acutely critically ill
patients, which may lack external validity in this setting.
Ventilator Weaning
As shown for ICU patients in prospective, randomized, con-
trolled trials, a before–after study showed the effectiveness of
a protocol implemented by respiratory therapists for weaning
patients with tracheotomy from prolonged mechanical ventila-
tion in a long-term acute care facility (51). Median time to
ventilator liberation was 17 days during an 18-month period
after the protocol was implemented, compared with 29 days in
a historical control group. Therapists used a rapid shallow
breathing index (RSBI) of no more than 80 as an ‘‘acceleration
step’’ to advance patients to spontaneous breathing trials. A
subsequent prospective observational study found that a higher
threshold RSBI of 100 (as used in patients with shorter term
ventilation) accelerated weaning without significantly lowering
the specificity of the index (52). In many LTACs and other
venues, weaning protocols are successfully managed by non-
physicians (19, 53). Typically, trials of pressure support at a level
(10–15 cm H2O) that is approximately half of full ventilator
support are followed by spontaneous breathing trials, using
a ‘‘trach collar’’ or ‘‘T-piece approach’’ for progressively in-
creasing periods (2, 43). Standardized criteria can be used to
assess readiness for final removal of a tracheotomy tube
(‘‘decannulation’’) after ventilator liberation (54).
Nutritional Support
Beyond ventilator weaning, the syndrome of chronic critical
illness calls for a broader, multidisciplinary, therapeutic ap-
proach that addresses all major clinical features (Figure 2).
Strategies have been suggested, but not empirically tested, to
address the kwashiorkor-like malnourished state (6). Rational
goals of nutritional support reflect a balancing of potential
benefits of providing metabolic substrates to minimize further
loss of lean body mass against adverse consequences of over-
feeding and other risks. For the patient with a functional
gastrointestinal tract, enteral feeding is recommended as first-
line therapy, and observational evidence favors placement of
a percutaneous endoscopic gastrostomy or jejunostomy for
nutritional support to exceed 30 days (55). Stress hyperglyce-
mia, originating during acute critical illness, typically persists
and requires insulinization.
Functional and Cognitive Recovery
Integration of physical therapy in a comprehensive rehabilita-
tive model for care is supported by a consensus of expert
opinion (2) and by evidence emerging from the setting of acute
critical illness, which indicates that early mobilization may
mitigate development, severity, and/or duration of post-ICU
muscle weakness (56). Initiation of this approach during the
chronic phase of critical illness, when the patient is already
cachectic, profoundly weak, and debilitated, has not yet been
specifically studied. Biochemical evidence supports treatment
with calcitriol and pamidronate to attenuate accelerated bone
loss (22), but clinical implications for recovery of strength or
function remain unclear. Although some data suggest that
sedation and analgesia can be reduced after tracheotomy (57),
it is not known whether this will decrease the prevalence or
prolonged duration of brain dysfunction. Extrapolation from
the acute ICU setting suggests that, because of their deliriogenic
potential (58, 59), benzodiazepines should be avoided as
possible. Haloperidol and newer atypical antipsychotics such
as ziprasidone have been recommended for control of agitation
or delirium in the ICU, but data are limited regarding their
efficacy in reducing delirium, especially the hypoactive form
(60).
Preventing Complications
Attempts to prevent and treat infectious and other complica-
tions, which cause morbidity, mortality, and persistent ventila-
tory insufficiency (61), require assiduous efforts. Patients face
a ‘‘triple threat’’ of risk of infection, the most common
complication (10): barrier breaches, such as intravenous cathe-
terization and skin breakdown; exposure to virulent and re-
Figure 2. Comprehensive care for the
chronically critically ill. Comprehensive care
for the chronically critically ill includes mul-
tiple components, as illustrated here and
discussed more fully in text, with five key
goals: ventilator liberation, nutritional sup-
port, cognitive and functional recovery, pre-
vention of complications, and attention to
palliative needs. Given the unique and com-
plex challenges, a dedicated interdisciplin-
ary team of professionals may be best
equipped to provide this care.
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sistant pathogens in ICU and post–ICU care environments; and
postulated ‘‘immune exhaustion’’ from recent critical illness and
comorbidities (9). Processes of care should be systematized to
maximize use of essential preventive measures such as hand-
washing, isolation, removal of unnecessary indwelling catheters,
restriction of antibiotic use, and best practices for maintaining
skin integrity (12). Source identification and control should
focus first on possible line sepsis, pneumonia, and Clostridium
difficile colitis, which account for the majority of infections (9).
Care Models
Effective and efficient care can be provided to the chronically
critically ill outside of the ICU, either in specialized in-hospital
units or free-standing facilities, with lower levels of nursing
intensity, technology, and ancillary care (62). In these venues,
nurses have played a key role in structuring and managing care
by an interdisciplinary team that is dedicated to the special needs
of this resource-intensive patient group (12, 62). A ‘‘mobile’’
team led by advanced practice nurses using a protocol-based
approach improved outcomes and reduced costs for ICU pa-
tients requiring mechanical ventilation for more than 3 days
(63).
Tracheotomy Timing and Other Issues
Although placement of a tracheotomy for patients with pro-
longed weaning failure is a clinical marker of the transition
between the acute and chronic phases of critical illness, there is
debate about whether earlier placement of a tracheotomy can
reduce ventilator days and therefore reduce the likelihood of
complications that can lead to chronic critical illness (64).
Multicenter trials designed to help resolve this debate are
ongoing, while the average time from initiation of mechanical
ventilation to tracheotomy placement is decreasing in clinical
practice (18, 65). It is likely that other evidence-based practices
that reduce ventilator days for patients in the acute ICU setting
will help to decrease the incidence of chronic critical illness
when applied systematically during the acute phase. Efficient
liberation from mechanical ventilation requires organized ICU
management practices, preferably directed by certified intensiv-
ists in a ‘‘closed’’ ICU model (66, 67). Weaning protocols should
include daily spontaneous breathing trials (68), daily lightening
of continuous sedatives (69), and avoidance of long-acting
sedatives (70), as all of these strategies shorten duration of
mechanical ventilation and ICU length of stay. Systematic
approaches to prevention of ventilator-associated pneumonia
and central line–associated bloodstream infections are sup-
ported by existing evidence (71).
Palliative Care
Palliative care is an essential component of comprehensive
treatment for all chronically critically ill patients, including
those receiving life-prolonging therapies. This care includes
sensitive, effective, proactive, and ongoing communication with
patients and families about prognosis, achievable goals of
treatment, and alternatives to continuation of critical care
(20). Ideally, goals should be defined by the patient’s prefer-
ences for treatment and views of acceptable function and
quality of life, but most chronically critically ill patients are
unable to participate directly in discussions or decision-making
and few have designated a surrogate decision-maker or pre-
pared another advance directive (72). A prospective study
showed that treatment and decision-making in chronic critical
illness generally proceeded without direct input from the
patient (most lacked capacity when critical illness became
chronic and 85% lacked an advance directive expressing
treatment preferences) (72). Limitation (withholding or with-
drawal) of life-supporting therapies (mechanical ventilation,
renal replacement therapy, artificial nutrition, intravenous
hydration, or vasopressors) was rare—fewer than 1 in 5 (39 of
203) patients—and late in the course (median, 39 d from
hospital admission), when the patient was near death. In
another study, one-third of family surrogates denied any role
in deciding to continue mechanical ventilation for a prolonged
period, stating their understanding that this decision was made
exclusively by the physician (39).
To ensure meaningful participation by patients and families
who wish to share in decision-making, clinicians should engage
them in a mutual exchange, providing relevant medical in-
formation in terms that are clear and understandable to
a layperson, while investigating the patient’s values and goals.
A new model based on four simple measures may be useful to
estimate 1-year survival of patients requiring prolonged me-
chanical ventilation (25). The use of objective mortality pre-
diction models for guiding discussions of prognosis and goals of
care is controversial. The SUPPORT (Study to Understand
Prognoses and Preferences for Outcomes and Risks of Treat-
ments) study, which tested communication of model-derived
prognostic information from physicians to patients through
a research nurse intermediary, did not favorably alter physician
behavior or clinical outcomes for seriously ill patients hospital-
ized with acute illness (73). It is possible, however, that a simpler
model designed to identify chronically critically ill patients who
are at the greatest risk for mortality with a high degree of
specificity will allow clinicians to be more confident in discus-
sing poor prognoses directly. Patients, families, and even
clinicians may fail to appreciate the ongoing risks of death or
severe disability when the patient has just survived the acute
phase of critical illness (20, 39). A new brochure about chronic
critical illness is available as an adjunct to direct clinician
counseling for education of patients and families (74); the value
of printed informational materials for this purpose has been
shown in randomized, controlled trials (75, 76). In a randomized,
controlled, multicenter trial that is newly funded by the
National Institutes of Health, this brochure will be given to
families of chronically critically ill patients in both the control
and intervention groups; in addition, a ‘‘Supportive Information
Team’’ including a palliative care physician and nurse, which
the ICU attending physician will have the option to join, will
conduct proactive meetings with families in the intervention
group.
Interdisciplinary support addressing families’ emotional,
spiritual, and practical needs is helpful as a framework for
discussions and decision-making about continuation of intensive
care therapies when critical illness enters a chronic phase.
Palliative care consultants are increasingly available to help
with communication challenges and provide other support for
patients and families, as well as to optimize symptom control
and transitional planning. Early integration of palliative care
with treatments for cure or longer life, ideally from admission to
the ICU and through the chronic phase, is recommended.
CONCLUSION
In their 1985 article, Girard and Raffin asked whether we
should attempt to save the chronically critically ill or let them
die (1). This question remains immediately relevant, but the
present state of the evidence, 25 years later, does not yet
support a definite response. Various factors have made it
difficult for research on chronic critical illness to progress more
quickly. The successes of acute critical care in achieving short-
term survival have partly obscured the scope and severity of the
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problem of chronic critical illness, delaying the emergence of
this area as an important focus of scientific investigation.
Another barrier is the diversity of venues in which care is
currently provided to the chronically critically ill, compounding
the problem of generalization from one setting to another while
also increasing the challenge of recruiting large cohorts for
research. To move forward at a pace that matches the increasing
incidence of this condition and the magnitude of its impact, the
field needs consensus on a definition. We suggest that place-
ment of a tracheotomy after at least 10 days of mechanical
ventilation be used to define the onset of chronic critical illness
because this definition incorporates the clinician’s judgment
that the patient is not expected to die or to wean from the
ventilator in the immediate future. Although it may not be
necessary or possible for all studies of chronic critical illness to
conform exactly to this definition (e.g., studies using adminis-
trative data as currently classified) (17), a common definition
would be beneficial for interventional studies in which patients
are prospectively enrolled. We also suggest that federal funds
be dedicated to support the development of a large research
network encompassing a broad range of venues for care of the
chronically critically ill. Pathobiology and pathophysiology of
chronic as distinct from acute critical illness deserve further
scientific investigation. We also need well-designed trials testing
approaches to the many clinical challenges, from management
of prolonged mechanical ventilation to nutritional support to
treatment of delirium, symptom distress, and physical weakness.
Regarding appropriate venues for care, current evidence lags
far behind trends in practice. Comparative effectiveness re-
search that includes detailed economic analyses should be
conducted to compare the cost-effectiveness of transferring
chronically critically ill patients from acute hospitals to special-
ized facilities (77). Whereas existing evidence for optimal
management strategies remains limited, data on long-term
outcomes are available and clear. These data should not be
ignored during discussions with patients and their families about
appropriate goals of continuing intensive care therapies when
critical illness becomes chronic.
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